Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities
Abstract
:1. Introduction
2. Materials and Methods
3. Results
3.1. Epidemiology
3.2. Risk Factors
3.3. COVID-19 Infection and Neuro-Pathogenesis
3.4. Linking of Mitochondrion Dysfunction, Ischemia, and COVID-19 Infection
3.5. Diagnostic Assessment
3.6. Management Issues
3.7. Severity and Prognosis
3.8. Preventive Measures
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Keyhanian, K.; Umeton, R.P.; Mohit, B.; Davoudi, V.; Hajighasemi, F.; Ghasemi, M. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J. Neuroimmunol. 2020, 350, 577436. [Google Scholar] [CrossRef]
- Singh, A.; Shaikh, A.; Singh, R.; Singh, A.K. COVID-19: From bench to bed side. Diabetes Metab. Syndr. Clin. Res. Rev. 2020, 14, 277–281. [Google Scholar] [CrossRef]
- Zhu, N.; Zhang, D.; Wang, W.; Li, X.; Yang, B.; Song, J.; Zhao, X.; Huang, B.; Shi, W.; Lu, R.; et al. A Novel Coronavirus from Patients with Pneumonia in China. N. Engl. J. Med. 2019, 382, 727–733. [Google Scholar] [CrossRef]
- De Wilde, A.H.; Snijder, E.J.; Kikkert, M.; van Hemert, M.J. Host Factors in Coronavirus Replication. Curr. Top. Microbiol. Immunol. 2017, 419, 1–42. [Google Scholar] [CrossRef] [Green Version]
- Weiss, S.R.; Leibowitz, J.L. Coronavirus Pathogenesis. Adv. Virus Res. 2011, 81, 85–164. [Google Scholar] [CrossRef]
- Montemurro, N. Intracranial hemorrhage and COVID-19, but please do not forget “old diseases” and elective surgery. Brain Behav. Immun. 2021, 92, 207–208. [Google Scholar] [CrossRef] [PubMed]
- Zhu, F.C.; Li, Y.H.; Guan, X.H.; Hou, L.J.; Wang, W.X.; Li, J.; Wu, S.; Wang, B.; Wang, Z.; Wang, L.; et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: A dose-escalation, open-label, non-randomised, first-in-human trial. Lancet 2020, 395, 1845–1854. [Google Scholar] [CrossRef]
- Montemurro, N. The emotional impact of COVID-19: From medical staff to common people. Brain Behav. Immun. 2020, 87, 23–24. [Google Scholar] [CrossRef]
- Bassetti, M.; Vena, A.; Giacobbe, D.R. The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm. Eur. J. Clin. Investig. 2020, 50, e13209. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bai, Y.; Yao, L.; Wei, T.; Tian, F.; Jin, D.Y.; Chen, L.; Wang, M. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 2020, 323, 1406–1407. [Google Scholar] [CrossRef] [Green Version]
- Sagui, E.; M’Baye, P.S.; Dubecq, C.; Fall, K.B.; Niang, A.; Gning, S.; Bellefleur, J.-P.; Sane, M.; Debonne, J.M. Ischemic and Hemorrhagic Strokes in Dakar, Senegal: A hospital-based study. Stroke 2005, 36, 1844–1847. [Google Scholar] [CrossRef] [Green Version]
- Cascella, M.; Rajnik, M.; Aleem, A.; Dulebohn, S.C.; Di Napoli, R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2022. [Google Scholar]
- Liotta, E.M.; Batra, A.; Clark, J.R.; Shlobin, N.A.; Hoffman, S.C.; Orban, Z.S.; Koralnik, I.J. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann. Clin. Transl. Neurol. 2020, 7, 2221–2230. [Google Scholar] [CrossRef]
- Mao, L.; Jin, H.; Wang, M.; Hu, Y.; Chen, S.; He, Q.; Chang, J.; Hong, C.; Zhou, Y.; Wang, D.; et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020, 77, 683–690. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pezzini, A.; Padovani, A. Lifting the mask on neurological manifestations of COVID-19. Nat. Rev. Neurol. 2020, 16, 636–644. [Google Scholar] [CrossRef] [PubMed]
- Wang, A.; Mandigo, G.K.; Yim, P.D.; Meyers, P.M.; LaVine, S.D. Stroke and mechanical thrombectomy in patients with COVID-19: Technical observations and patient characteristics. J. NeuroInterv. Surg. 2020, 12, 648–653. [Google Scholar] [CrossRef]
- Romero-Sánchez, C.M.; Díaz-Maroto, I.; Fernández-Díaz, E.; Sánchez-Larsen, Á.; Layos-Romero, A.; García-García, J.; González, E.; Redondo-Peñas, I.; Perona-Moratalla, A.B.; Del Valle-Pérez, J.A.; et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology 2020, 95, e1060–e1070. [Google Scholar] [CrossRef] [PubMed]
- Li, B.; Si, H.-R.; Zhu, Y.; Yang, X.-L.; Anderson, D.E.; Shi, Z.-L.; Wang, L.-F.; Zhou, P. Discovery of Bat Coronaviruses through Surveillance and Probe Capture-Based Next-Generation Sequencing. mSphere 2020, 5, e00807-19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Toljan, K. Letter to the Editor Regarding the Viewpoint “Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanism”. ACS Chem. Neurosci. 2020, 11, 1192–1194. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cooper, K.; Brann, D.H.; Farruggia, M.C.; Bhutani, S.; Pellegrino, R.; Tsukahara, T.; Weinreb, C.; Joseph, P.V.; Larson, E.D.; Parma, V.; et al. COVID-19 and the Chemical Senses: Supporting Players Take Center Stage. Neuron 2020, 107, 219–233. [Google Scholar] [CrossRef]
- Uversky, V.N.; Elrashdy, F.; Aljadawi, A.; Ali, S.M.; Khan, R.H.; Redwan, E.M. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How? J. Neurosci. Res. 2021, 99, 750–777. [Google Scholar] [CrossRef]
- Bekelis, K.; Missios, S.; Ahmad, J.; Labropoulos, N.; Schirmer, C.M.; Calnan, D.R.; Skinner, J.; MacKenzie, T.A. Ischemic Stroke Occurs Less Frequently in Patients with COVID-19: A Multicenter Cross-Sectional Study. Stroke 2020, 51, 3570–3576. [Google Scholar] [CrossRef]
- Beyrouti, R.; Adams, M.E.; Benjamin, L.; Cohen, H.; Farmer, S.F.; Goh, Y.Y.; Humphries, F.; Jäger, H.R.; Losseff, N.A.; Perry, R.J.; et al. Characteristics of ischaemic stroke associated with COVID-19. J. Neurol. Neurosurg. Psychiatry 2020, 91, 889–891. [Google Scholar] [CrossRef] [PubMed]
- Yaghi, S.; Ishida, K.; Torres, J.; Mac Grory, B.; Raz, E.; Humbert, K.; Henninger, N.; Trivedi, T.; Lillemoe, K.; Alam, S.; et al. SARS-CoV-2 and Stroke in a New York Healthcare System. Stroke 2020, 51, 2002–2011. [Google Scholar] [CrossRef] [PubMed]
- Cantador, E.; Núñez, A.; Sobrino, P.; Espejo, V.; Fabia, L.; Vela, L.; De Benito, L.; Botas, J. Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients. J. Thromb. Thrombolysis 2020, 50, 543–547. [Google Scholar] [CrossRef] [PubMed]
- Dogra, S.; Jain, R.; Cao, M.; Bilaloglu, S.; Zagzag, D.; Hochman, S.; Lewis, A.; Melmed, K.; Hochman, K.; Horwitz, L.; et al. Hemorrhagic stroke and anticoagulation in COVID-19. J. Stroke Cerebrovasc. Dis. 2020, 29, 104984. [Google Scholar] [CrossRef] [PubMed]
- Hernández-Fernández, F.; Valencia, H.S.; Barbella-Aponte, R.A.; Collado-Jiménez, R.; Ayo-Martín, Ó.; Barrena, C.; Molina-Nuevo, J.D.; García-García, J.; Lozano-Setién, E.; Alcahut-Rodriguez, C.; et al. Cerebrovascular disease in patients with COVID-19: Neuroimaging, histological and clinical description. Brain 2020, 143, 3089–3103. [Google Scholar] [CrossRef]
- Klok, F.A.; Kruip, M.J.H.A.; van der Meer, N.J.M.; Arbous, M.S.; Gommers, D.; Kant, K.M.; Kaptein, F.H.J.; van Paassen, J.; Stals, M.A.M.; Huisman, M.V.; et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb. Res. 2020, 191, 148–150. [Google Scholar] [CrossRef]
- Hu, B.; Guo, H.; Zhou, P.; Shi, Z.-L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021, 19, 141–154, Correction in Nat. Rev. Microbiol. 2022, 20, 315. [Google Scholar] [CrossRef] [PubMed]
- Lodigiani, C.; Iapichino, G.; Carenzo, L.; Cecconi, M.; Ferrazzi, P.; Sebastian, T.; Kucher, N.; Studt, J.-D.; Sacco, C.; Bertuzzi, A.; et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb. Res. 2020, 191, 9–14. [Google Scholar] [CrossRef]
- Requena, M.; Olive-Gadea, M.; Muchada, M.; García-Tornel, Á.; Deck, M.; Juega, J.; Boned, S.; Rodríguez-Villatoro, N.; Piñana, C.; Pagola, J.; et al. COVID-19 and Stroke: Incidence and Etiological Description in a High-Volume Center. J. Stroke Cerebrovasc. Dis. 2020, 29, 105225. [Google Scholar] [CrossRef]
- Rothstein, A.; Oldridge, O.; Schwennesen, H.; Do, D.; Cucchiara, B.L. Acute Cerebrovascular Events in Hospitalized COVID-19 Patients. Stroke 2020, 51, e219–e222. [Google Scholar] [CrossRef]
- Katz, J.; Libman, R.; Wang, J.; Filippi, C.; Sanelli, P.; Zlochower, A.; Gribko, M.; Pacia, S.; Kuzniecky, R.; Najjar, S.; et al. COVID-19 Severity and Stroke: Correlation of Imaging and Laboratory Markers. AJNR Am. J. Neuroradiol. 2021, 42, 257–261. [Google Scholar] [CrossRef]
- Khatana, S.A.M.; Groeneveld, P.W. Health Disparities and the Coronavirus Disease 2019 (COVID-19) Pandemic in the USA. J. Gen. Intern. Med. 2020, 35, 2431–2432. [Google Scholar] [CrossRef]
- Al Saiegh, F.; Ghosh, R.; Leibold, A.; Avery, M.B.; Schmidt, R.F.; Theofanis, T.; Mouchtouris, N.; Philipp, L.; Peiper, S.C.; Wang, Z.-X.; et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J. Neurol. Neurosurg. Psychiatry 2020, 91, 846–848. [Google Scholar] [CrossRef]
- Sweid, A.; Hammoud, B.; Bekelis, K.; Missios, S.; Tjoumakaris, S.I.; Gooch, M.R.; Herial, N.A.; Zarzour, H.; Romo, V.; DePrince, M.; et al. Cerebral ischemic and hemorrhagic complications of coronavirus disease. Int. J. Stroke 2019, 15, 733–742. [Google Scholar] [CrossRef] [PubMed]
- Lin, E.; Lantos, J.; Strauss, S.; Phillips, C.; Campion, T.R., Jr.; Navi, B.; Parikh, N.; Merkler, A.; Mir, S.; Zhang, C.; et al. Brain Imaging of Patients with COVID-19: Findings at an Academic Institution during the Height of the Outbreak in New York City. AJNR Am. J. Neuroradiol. 2020, 41, 2001–2008. [Google Scholar] [CrossRef] [PubMed]
- Qi, X.; Keith, K.A.; Huang, J.H. COVID-19 and stroke: A review. Brain Hemorrhages 2021, 2, 76–83. [Google Scholar] [CrossRef]
- Panigada, M.; Bottino, N.; Tagliabue, P.; Grasselli, G.; Novembrino, C.; Chantarangkul, V.; Pesenti, A.; Peyvandi, F.; Tripodi, A. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J. Thromb. Haemost. 2020, 18, 1738–1742. [Google Scholar] [CrossRef]
- Tan, C.W.; Low, J.G.H.; Wong, W.H.; Chua, Y.Y.; Goh, S.L.; Ng, H.J. Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability. Am. J. Hematol. 2020, 95, E156–E158. [Google Scholar] [CrossRef]
- Boehme, A.K.; Esenwa, C.; Elkind, M.S.V. Stroke Risk Factors, Genetics, and Prevention. Circ. Res. 2017, 120, 472–495. [Google Scholar] [CrossRef] [PubMed]
- Tian, D.; Yang, Q.; Dong, Q.; Li, N.; Yan, B.; Fan, D. Trends in stroke subtypes and vascular risk factors in a stroke center in China over 10 years. Sci. Rep. 2018, 8, 5037. [Google Scholar] [CrossRef] [Green Version]
- Wijeratne, T.; Sales, C.; Karimi, L.; Crewther, S.G. Acute Ischemic Stroke in COVID-19: A Case-Based Systematic Review. Front. Neurol. 2020, 11, 1031. [Google Scholar] [CrossRef]
- Belani, P.; Schefflein, J.; Kihira, S.; Rigney, B.; Delman, B.; Mahmoudi, K.; Mocco, J.; Majidi, S.; Yeckley, J.; Aggarwal, A.; et al. COVID-19 Is an Independent Risk Factor for Acute Ischemic Stroke. AJNR Am. J. Neuroradiol. 2020, 41, 1361–1364. [Google Scholar] [CrossRef] [PubMed]
- Escalard, S.; Maïer, B.; Redjem, H.; Delvoye, F.; Hébert, S.; Smajda, S.; Ciccio, G.; Desilles, J.-P.; Mazighi, M.; Blanc, R.; et al. Treatment of Acute Ischemic Stroke due to Large Vessel Occlusion With COVID-19: Experience From Paris. Stroke 2020, 51, 2540–2543. [Google Scholar] [CrossRef]
- Montemurro, N.; Murrone, D.; Romanelli, B.; Ierardi, A. Postoperative Textiloma Mimicking Intracranial Rebleeding in a Patient with Spontaneous Hemorrhage: Case Report and Review of the Literature. Case Rep. Neurol. 2020, 12, 7–12. [Google Scholar] [CrossRef] [PubMed]
- Oxley, T.J.; Mocco, J.; Majidi, S.; Kellner, C.P.; Shoirah, H.; Singh, I.P.; De Leacy, R.A.; Shigematsu, T.; Ladner, T.R.; Yaeger, K.A.; et al. Large-Vessel Stroke as a Presenting Feature of COVID-19 in the Young. N. Engl. J. Med. 2020, 382, e60. [Google Scholar] [CrossRef]
- Deana, C.; Bagatto, D. Severe stroke in patients admitted to intensive care unit after COVID-19 infection: Pictorial essay of a case series. Brain Hemorrhages 2021, 3, 29–35. [Google Scholar] [CrossRef]
- Deana, C.; Verriello, L.; Pauletto, G.; Corradi, F.; Forfori, F.; Cammarota, G.; Bignami, E.; Vetrugno, L.; Bove, T. Insights into neurological dysfunction of critically ill COVID-19 patients. Trends Anaesth. Crit. Care 2021, 36, 30–38. [Google Scholar] [CrossRef]
- Merkler, A.E.; Parikh, N.S.; Mir, S.; Gupta, A.; Kamel, H.; Lin, E.; Lantos, J.; Schenck, E.J.; Goyal, P.; Bruce, S.S.; et al. Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. JAMA Neurol. 2020, 77, 1366–1367. [Google Scholar] [CrossRef]
- Bouck, E.G.; Denorme, F.; Holle, L.A.; Middelton, E.A.; Blair, A.; De Laat, B.; Schiffman, J.D.; Yost, C.C.; Rondina, M.T.; Wolberg, A.S.; et al. COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity. Arter. Thromb. Vasc. Biol. 2020, 41, 401–414. [Google Scholar] [CrossRef]
- Perry, R.J.; Smith, C.J.; Roffe, C.; Simister, R.J.; Narayanamoorthi, S.; Marigold, R.; Willmot, M.; Dixit, A.; Hassan, A.; Quinn, T.J.; et al. Characteristics and outcomes of COVID-19 associated stroke: A UK multicentre case-control study. J. Neurol. Neurosurg. Psychiatry 2021, 92, 242–248. [Google Scholar] [CrossRef]
- Zhang, Y.; Xiao, M.; Zhang, S.; Xia, P.; Cao, W.; Jiang, W.; Chen, H.; Ding, X.; Zhao, H.; Zhang, H.; et al. Coagulopathy and Antiphospholipid Antibodies in Patients with COVID-19. N. Engl. J. Med. 2020, 382, e38. [Google Scholar] [CrossRef]
- Denorme, F.; Portier, I.; Rustad, J.L.; Cody, M.J.; de Araujo, C.V.; Hoki, C.; Alexander, M.D.; Grandhi, R.; Dyer, M.R.; Neal, M.D.; et al. Neutrophil extracellular traps regulate ischemic stroke brain injury. J. Clin. Investig. 2022, 31, 154225. [Google Scholar] [CrossRef]
- Middleton, E.A.; He, X.-Y.; Denorme, F.; Campbell, R.A.; Ng, D.; Salvatore, S.P.; Mostyka, M.; Baxter-Stoltzfus, A.; Borczuk, A.C.; Loda, M.; et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 2020, 136, 1169–1179. [Google Scholar] [CrossRef]
- Zuo, Y.; Yalavarthi, S.; Shi, H.; Gockman, K.; Zuo, M.; Madison, J.A.; Blair, C.N.; Weber, A.; Barnes, B.J.; Egeblad, M.; et al. Neutrophil extracellular traps in COVID-19. JCI Insight 2020, 5, e138999. [Google Scholar] [CrossRef] [Green Version]
- Veras, F.P.; Pontelli, M.C.; Silva, C.M.; Toller-Kawahisa, J.E.; de Lima, M.; Nascimento, D.C.; Schneider, A.H.; Caetité, D.; Tavares, L.A.; Paiva, I.M.; et al. SARS-CoV-2—Triggered neutrophil extracellular traps mediate COVID-19 pathology. J. Exp. Med. 2020, 217, 20201129. [Google Scholar] [CrossRef]
- Radermecker, C.; Detrembleur, N.; Guiot, J.; Cavalier, E.; Henket, M.; D’Emal, C.; Vanwinge, C.; Cataldo, D.; Oury, C.; Delvenne, P.; et al. Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19. J. Exp. Med. 2020, 217, 20201012. [Google Scholar] [CrossRef]
- Zuo, Y.; Estes, S.K.; Ali, R.A.; Gandhi, A.A.; Yalavarthi, S.; Shi, H.; Sule, G.; Gockman, K.; Madison, J.A.; Zuo, M.; et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci. Transl. Med. 2020, 12, 3876. [Google Scholar] [CrossRef]
- Szekely, Y.; Lichter, Y.; Taieb, P.; Banai, A.; Hochstadt, A.; Merdler, I.; Oz, A.G.; Rothschild, E.; Baruch, G.; Peri, Y.; et al. Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation 2020, 142, 342–353. [Google Scholar] [CrossRef]
- Yang, X.; Hu, M.; Yu, Y.; Zhang, X.; Fang, M.; Lian, Y.; Peng, Y.; Wu, L.; Wu, Y.; Yi, J.; et al. Extracorporeal Membrane Oxygenation for SARS-CoV-2 Acute Respiratory Distress Syndrome: A Retrospective Study From Hubei, China. Front. Med. 2021, 7, 611460. [Google Scholar] [CrossRef]
- Bhatia, R.; Pedapati, R.; Komakula, S.; Srivastava, M.P.; Vishnubhatla, S.; Khuranac, D. Stroke in Coronavirus Disease 2019: A Systematic Review. J. Stroke 2020, 22, 324–335. [Google Scholar] [CrossRef]
- Bhatia, R.; Srivastava, M.P. COVID-19 and Stroke: Incidental, Triggered or Causative. Ann. Indian Acad. Neurol. 2020, 23, 318–324. [Google Scholar] [CrossRef]
- Carod-Artal, F.J. Neurological complications of coronavirus and COVID-19. Rev. Neurol. 2020, 70, 311–322. [Google Scholar] [CrossRef] [PubMed]
- Meinhardt, J.; Radke, J.; Dittmayer, C.; Franz, J.; Thomas, C.; Mothes, R.; Laue, M.; Schneider, J.; Brünink, S.; Greuel, S.; et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021, 24, 168–175. [Google Scholar] [CrossRef]
- Song, E.; Zhang, C.; Israelow, B.; Lu-Culligan, A.; Prado, A.V.; Skriabine, S.; Lu, P.; Weizman, O.-E.; Liu, F.; Dai, Y.; et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 2021, 218, e20202135. [Google Scholar] [CrossRef]
- Spence, J.D.; De Freitas, G.R.; Pettigrew, L.C.; Ay, H.; Liebeskind, D.S.; Kase, C.S.; Del Brutto, O.H.; Hankey, G.; Venketasubramanian, N. Mechanisms of Stroke in COVID-19. Cerebrovasc. Dis. 2020, 49, 451–458. [Google Scholar] [CrossRef]
- Varga, Z.; Flammer, A.J.; Steiger, P.; Haberecker, M.; Andermatt, R.; Zinkernagel, A.S.; Mehra, M.R.; Schuepbach, R.A.; Ruschitzka, F.; Moch, H. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020, 395, 1417–1418. [Google Scholar] [CrossRef]
- Goldsmith, C.S.; Miller, S.E.; Martines, R.B.; Bullock, H.A.; Zaki, S.R. Electron microscopy of SARS-CoV-2: A challenging task. Lancet 2020, 395, e99. [Google Scholar] [CrossRef]
- Varga, Z.; Flammer, A.J.; Steiger, P.; Haberecker, M.; Andermatt, R.; Zinkernagel, A.; Mehra, M.R.; Scholkmann, F.; Schüpbach, R.; Ruschitzka, F.; et al. Electron microscopy of SARS-CoV-2: A challenging task—Authors’ reply. Lancet 2020, 395, e100. [Google Scholar] [CrossRef]
- Hottz, E.D.; Martins-Gonçalves, R.; Palhinha, L.; Azevedo-Quintanilha, I.G.; de Campos, M.M.; Sacramento, C.Q.; Temerozo, J.R.; Soares, V.C.; Dias, S.S.G.; Teixeira, L.; et al. Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19. Blood Adv. 2022, 14, 1–3. [Google Scholar] [CrossRef]
- Hanafi, R.; Roger, P.-A.; Perin, B.; Kuchcinski, G.; Deleval, N.; Dallery, F.; Michel, D.; Hacein-Bey, L.; Pruvo, J.-P.; Outteryck, O.; et al. COVID-19 Neurologic Complication with CNS Vasculitis-Like Pattern. AJNR Am. J. Neuroradiol. 2020, 41, 1384–1387. [Google Scholar] [CrossRef]
- Keller, E.; Brandi, G.; Winklhofer, S.; Imbach, L.L.; Kirschenbaum, D.; Frontzek, K.; Steiger, P.; Dietler, S.; Haeberlin, M.; Willms, J.; et al. Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case Series. Stroke 2020, 51, 3719–3722. [Google Scholar] [CrossRef]
- Strawn, W.B.; Ferrario, C.M.; Tallant, E.A. Angiotensin-(1–7) Reduces Smooth Muscle Growth after Vascular Injury. Hypertension 1999, 33, 207–211. [Google Scholar] [CrossRef] [Green Version]
- Ye, M.; Wysocki, J.; William, J.; Soler, M.J.; Cokic, I.; Batlle, D. Glomerular Localization and Expression of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting Enzyme: Implications for Albuminuria in Diabetes. J. Am. Soc. Nephrol. 2006, 17, 3067–3075. [Google Scholar] [CrossRef] [Green Version]
- Muccioli, L.; Pensato, U.; Cani, I.; Guarino, M.; Cortelli, P.; Bisulli, F. COVID-19—Associated Encephalopathy and Cytokine-Mediated Neuroinflammation. Ann. Neurol. 2020, 88, 860–861. [Google Scholar] [CrossRef]
- Pilotto, A.; Padovani, A. ENCOVID-BIO Reply to the Letter “COVID-19-Associated Encephalopathy and Cytokine-Mediated Neuroinflammation”. Ann. Neurol. 2020, 88, 861–862. [Google Scholar] [CrossRef]
- Channappanavar, R.; Perlman, S. Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology. Semin. Immunopathol. 2017, 39, 529–539. [Google Scholar] [CrossRef]
- Chen, G.; Wu, D.; Guo, W.; Cao, Y.; Huang, D.; Wang, H.; Wang, T.; Zhang, X.; Chen, H.; Yu, H.; et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Investig. 2020, 130, 2620–2629. [Google Scholar] [CrossRef] [Green Version]
- Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. [Google Scholar] [CrossRef] [Green Version]
- Vanderbeke, L.; Van Mol, P.; Van Herck, Y.; De Smet, F.; Humblet-Baron, S.; Martinod, K.; Antoranz, A.; Arijs, I.; Boeckx, B.; Bosisio, F.M.; et al. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat. Commun. 2021, 12, 4117. [Google Scholar] [CrossRef]
- Rapone, B.; Ferrara, E.; Montemurro, N.; Converti, I.; Loverro, M.; Loverro, M.T.; Gnoni, A.; Scacco, S.; Siculella, L.; Corsalini, M.; et al. Oral Microbiome and Preterm Birth: Correlation or Coincidence? A Narrative Review. Open Access Maced. J. Med. Sci. 2020, 8, 123–132. [Google Scholar] [CrossRef]
- Connors, J.M.; Levy, J.H. Thromboinflammation and the hypercoagulability of COVID-19. J. Thromb. Haemost. 2020, 18, 1559–1561. [Google Scholar] [CrossRef] [PubMed]
- Fotuhi, M.; Mian, A.; Meysami, S.; Raji, C.A. Neurobiology of COVID-19. J. Alzheimer’s Dis. 2020, 76, 3–19. [Google Scholar] [CrossRef] [PubMed]
- Koralnik, I.J.; Tyler, K.L. COVID-19: A Global Threat to the Nervous System. Ann. Neurol. 2020, 88, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Magro, C.; Mulvey, J.J.; Berlin, D.; Nuovo, G.; Salvatore, S.; Harp, J.; Baxter-Stoltzfus, A.; Laurence, J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl. Res. 2020, 220, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Al-Dalahmah, O.; Thakur, K.T.; Nordvig, A.S.; Prust, M.L.; Roth, W.; Lignelli, A.; Uhlemann, A.-C.; Miller, E.H.; Kunnath-Velayudhan, S.; Del Portillo, A.; et al. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathol. Commun. 2020, 8, 147. [Google Scholar] [CrossRef] [PubMed]
- Lizana, J.; Reinoso, C.M.D.; Aliaga, N.; Marani, W.; Montemurro, N. Bilateral central retinal artery occlusion: An exceptional complication after frontal parasagittal meningioma resection. Surg. Neurol. Int. 2021, 12, 397. [Google Scholar] [CrossRef] [PubMed]
- Melegari, G.; Rivi, V.; Zelent, G.; Nasillo, V.; De Santis, E.; Melegari, A.; Bevilacqua, C.; Zoli, M.; Meletti, S.; Barbieri, A. Mild to Severe Neurological Manifestations of COVID-19: Cases Reports. Int. J. Environ. Res. Public Health 2021, 18, 3673. [Google Scholar] [CrossRef]
- Fox, S.E.; Akmatbekov, A.; Harbert, J.L.; Li, G.; Brown, J.Q.; Heide, R.S.V. Pulmonary and cardiac pathology in African American patients with COVID-19: An autopsy series from New Orleans. Lancet Respir. Med. 2020, 8, 681–686. [Google Scholar] [CrossRef]
- Chavda, V.; Jan, A.T.; Yadav, D. Mini-Review on SARS-CoV-2 Infection and Neurological Manifestations: A Perspective. CNS Neurol. Disord. Drug Targets 2021, 21, 210–216. [Google Scholar] [CrossRef]
- Holder, K.; Reddy, P.H. The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia. Neuroscientist 2020, 27, 331–339. [Google Scholar] [CrossRef] [PubMed]
- Marani, W.; Mannará, F.; Noda, K.; Kondo, T.; Ota, N.; Perrini, P.; Montemurro, N.; Kinoshita, Y.; Tsuji, S.; Kamiyama, H.; et al. Management of an Uncommon Complication: Anterior Choroidal Artery Occlusion by Posterior Clinoid Process Detected Through Intraoperative Monitoring After Clipping of Paraclinoid Aneurysm: 2-Dimensional Operative Video. Oper. Neurosurg. 2021, 21, E124–E125. [Google Scholar] [CrossRef] [PubMed]
- Yang, J.-L.; Mukda, S.; Chen, S.-D. Diverse roles of mitochondria in ischemic stroke. Redox Biol. 2018, 16, 263–275. [Google Scholar] [CrossRef]
- Saleh, J.; Peyssonnaux, C.; Singh, K.K.; Edeas, M. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion 2020, 54, 1–7. [Google Scholar] [CrossRef]
- Barlinn, K.; Siepmann, T.; Pallesen, L.-P.; Winzer, S.; Sedghi, A.; Schroettner, P.; Hochauf-Stange, K.; Prakapenia, A.; Moustafa, H.; de With, K.; et al. Universal laboratory testing for SARS-CoV-2 in hyperacute stroke during the COVID-19 pandemic. J. Stroke Cerebrovasc. Dis. 2020, 29, 105061. [Google Scholar] [CrossRef]
- Fatehi, P.; Hesam-Shariati, N.; Abouzaripour, M.; Fathi, F.; Shariati, M.B.H. Acute Ischemic and Hemorrhagic Stroke and COVID-19: Case Series. SN Compr. Clin. Med. 2020, 2, 2396–2401. [Google Scholar] [CrossRef]
- Dafer, R.M.; Osteraas, N.D.; Biller, J. Acute Stroke Care in the Coronavirus Disease 2019 Pandemic. J. Stroke Cerebrovasc. Dis. 2020, 29, 104881. [Google Scholar] [CrossRef] [PubMed]
- Leira, E.C.; Russman, A.N.; Biller, J.; Brown, D.L.; Bushnell, C.D.; Caso, V.; Chamorro, A.; Creutzfeldt, C.J.; Cruz-Flores, S.; Elkind, M.S.; et al. Preserving stroke care during the COVID-19 pandemic: Potential issues and solutions. Neurology 2020, 95, 124–133. [Google Scholar] [CrossRef] [PubMed]
- Wira, C.R.; Goyal, M.; Southerland, A.M.; Sheth, K.N.; McNair, N.D.; Khosravani, H.; Leonard, A.; Panagos, P. Pandemic Guidance for Stroke Centers Aiding COVID-19 Treatment Teams. Stroke 2020, 51, 2587–2592. [Google Scholar] [CrossRef] [PubMed]
- Co, C.O.C.; Yu, J.R.T.; Laxamana, L.C.; David-Ona, D.I.A. Intravenous Thrombolysis for Stroke in a COVID-19 Positive Filipino Patient, a Case Report. J. Clin. Neurosci. 2020, 77, 234–236. [Google Scholar] [CrossRef] [PubMed]
- Cheung, S.; Quiwa, J.C.; Pillai, A.; Onwu, C.; Tharayil, Z.J.; Gupta, R. Superior Mesenteric Artery Thrombosis and Acute Intestinal Ischemia as a Consequence of COVID-19 Infection. Am. J. Case Rep. 2020, 21, e925753. [Google Scholar] [CrossRef]
- Tang, N.; Li, D.; Wang, X.; Sun, Z. Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020, 18, 844–847. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tsivgoulis, G.; Katsanos, A.H.; Ornello, R.; Sacco, S. Ischemic Stroke Epidemiology During the COVID-19 Pandemic: Navi-gating Uncharted Waters with Changing Tides. Stroke 2020, 51, 1924–1926. [Google Scholar] [CrossRef]
- Tsivgoulis, G.; Palaiodimou, L.; Zand, R.; Lioutas, V.A.; Krogias, C.; Katsanos, A.H.; Shoamanesh, A.; Sharma, V.K.; Shahjouei, S.; Baracchini, C.; et al. COVID-19 and cerebrovascular diseases: A comprehensive overview. Ther. Adv. Neurol. Disord. 2020, 13, 1756286420978004. [Google Scholar] [CrossRef] [PubMed]
- Dmytriw, A.; Phan, K.; Schirmer, C.; Settecase, F.; Heran, M.K.S.; Efendizade, A.; Kühn, A.L.; Puri, A.S.; Menon, B.K.; Dibas, M.; et al. Ischaemic stroke associated with COVID-19 and racial outcome disparity in North America. J. Neurol. Neurosurg. Psychiatry 2020, 91, 1362–1364. [Google Scholar] [CrossRef]
- Zhai, P.; Ding, Y.; Li, Y. The impact of COVID-19 on ischemic stroke. Diagn. Pathol. 2020, 15, 78. [Google Scholar] [CrossRef] [PubMed]
- Corsalini, M.; Di Venere, D.; Sportelli, P.; Magazzino, D.; Ripa, C.; Cantatore, F.; Cagnetta, G.; De Rinaldis, C.; Montemurro, N.; De Giacomo, A.; et al. Evaluation of prosthetic quality and masticatory efficiency in patients with total removable prosthesis: Study of 12 cases. Oral Implantol. 2018, 11, 230–240. [Google Scholar]
- Fisicaro, F.; Di Napoli, M.; Liberto, A.; Fanella, M.; Di Stasio, F.; Pennisi, M.; Bella, R.; Lanza, G.; Mansueto, G. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective. Int. J. Environ. Res. Public Health 2021, 18, 1415. [Google Scholar] [CrossRef]
- Chang, B.P.; Rostanski, S.; Willey, J.; Miller, E.C.; Shapiro, S.; Mehendale, R.; Kummer, B.; Navi, B.B.; Elkind, M.S. Safety and Feasibility of a Rapid Outpatient Management Strategy for Transient Ischemic Attack and Minor Stroke: The Rapid Access Vascular Evaluation—Neurology (RAVEN) Approach. Ann. Emerg. Med. 2019, 74, 562–571. [Google Scholar] [CrossRef]
- Montemurro, N.; Perrini, P. Will COVID-19 change neurosurgical clinical practice? Br. J. Neurosurg. 2020, 1–2. [Google Scholar] [CrossRef] [PubMed]
- Wang, C.-C.; Chao, J.-K.; Wang, M.-L.; Yang, Y.-P.; Chien, C.-S.; Lai, W.-Y.; Chang, Y.-H.; Chou, C.-L.; Kao, C.-L. Care for Patients with Stroke During the COVID-19 Pandemic: Physical Therapy and Rehabilitation Suggestions for Preventing Secondary Stroke. J. Stroke Cerebrovasc. Dis. 2020, 29, 105182. [Google Scholar] [CrossRef] [PubMed]
- Montemurro, N. Telemedicine: Could it represent a new problem for spine surgeons to solve? Glob. Spine J. 2022, 1, 21925682221090891. [Google Scholar] [CrossRef] [PubMed]
- Garcia-Esperon, C.; Chew, B.L.A.; Minett, F.; Cheah, J.; Rutherford, J.; Wilsmore, B.; Parsons, M.W.; Levi, C.R.; Spratt, N.J. Impact of an outpatient telestroke clinic on management of rural stroke patients. Aust. J. Rural Health 2022, 12, 1–5. [Google Scholar] [CrossRef]
- Zhou, F.; Yu, T.; Du, R.; Fan, G.; Liu, Y.; Liu, Z.; Xiang, J.; Wang, Y.; Song, B.; Gu, X.; et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020, 395, 1054–1062. [Google Scholar] [CrossRef]
- ATTACC Investigators; ACTIV-4a Investigators; REMAP-CAP Investigators; Lawler, P.R.; Goligher, E.C.; Berger, J.S.; Lawler, P.R.; Berger, J.S.; Gong, M.N.; Carrier, M.; et al. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with COVID-19. N. Engl. J. Med. 2021, 385, 790–802. [Google Scholar] [CrossRef]
- REMAP-CAP Investigators; ACTIV-4a Investigators; ATTACC Investigators; Goligher, E.C.; Bradbury, C.A.; McVerry, B.J.; Neal, M.D.; McVerry, B.J.; Nicolau, J.C.; Gong, M.N.; et al. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with COVID-19. N. Engl. J. Med. 2021, 385, 777–789. [Google Scholar] [CrossRef] [PubMed]
- Berger, J.S.; Kornblith, L.Z.; Gong, M.N.; Reynolds, H.R.; Cushman, M.; Cheng, Y.; McVerry, B.J.; Kim, K.S.; Lopes, R.D.; Atassi, B.; et al. Effect of P2Y12 Inhibitors on Survival Free of Organ Support among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial. J. Am. Med. Assoc. 2022, 327, 227–236. [Google Scholar] [CrossRef] [PubMed]
- Chow, J.H.; Rahnavard, A.; Gomberg-Maitland, M.; Chatterjee, R.; Patodi, P.; Yamane, D.P.; Levine, A.R.; Davison, D.; Hawkins, K.; Jackson, A.M.; et al. Association of Early Aspirin Use With In-Hospital Mortality in Patients with Moderate COVID-19. JAMA Netw. Open 2022, 5, e223890. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chavda, V.; Chaurasia, B.; Fiorindi, A.; Umana, G.E.; Lu, B.; Montemurro, N. Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities. Neurol. Int. 2022, 14, 391-405. https://doi.org/10.3390/neurolint14020032
Chavda V, Chaurasia B, Fiorindi A, Umana GE, Lu B, Montemurro N. Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities. Neurology International. 2022; 14(2):391-405. https://doi.org/10.3390/neurolint14020032
Chicago/Turabian StyleChavda, Vishal, Bipin Chaurasia, Alessandro Fiorindi, Giuseppe E. Umana, Bingwei Lu, and Nicola Montemurro. 2022. "Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities" Neurology International 14, no. 2: 391-405. https://doi.org/10.3390/neurolint14020032
APA StyleChavda, V., Chaurasia, B., Fiorindi, A., Umana, G. E., Lu, B., & Montemurro, N. (2022). Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities. Neurology International, 14(2), 391-405. https://doi.org/10.3390/neurolint14020032